Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Morpholine, 4-(2-chloroethyl)-, hydrochloride (1:1) | HCID 77210 | — |
| Reactant | HCID 86665050 | HCID 86665050 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 86665049 | HCID 86665049 | 43% |
Reaction Steps
To a suspension of (S)-ethyl 6-bromo-4-oxo-1-(piperidin-3-yl)-1,4-dihydro-1,7-naphthyridine-3-carboxylate hydrochloride (Intermediate 62, 1 g, 2.4 mmol, 1 equiv.) in acetonitrile (6 mL) was added 4-(2-chloroethyl)morpholine hydrochloride (447 mg, 2.4 mmol, 1 equiv.) followed by sodium iodide (360 mg, 2.4 mmol, 1 equiv.) and potassium carbonate (1.66 g, 12 mmol, 5 equiv.). This was stirred in the microwave at 120° C. for 30 min. The reaction was cooled to room temperature and diluted with ethyl acetate. The precipitates were removed, and the filtrate was concentrated to provide (S)-ethyl 6-bromo-1-(1-(2-morpholinoethyl)piperidin-3-yl)-4-oxo-1,4-dihydro-1,7-naphthyridine-3-carboxylate as a solid (501.3 mg, 43%). Calcd for C22H29BrN4O4 [M+H]+: 495.07.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08569484B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-1464187319f947cd8fbda667023c56b6 |
|---|
| Source note | uspto-grants-2013_10 |
|---|